Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $200,520 - $263,739
-27,850 Reduced 35.86%
49,814 $375,000
Q1 2023

May 10, 2023

BUY
$8.36 - $11.37 $649,271 - $883,039
77,664 New
77,664 $687,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $1.69 Million - $2.05 Million
-201,589 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$9.9 - $11.56 $518,383 - $605,304
52,362 Added 35.09%
201,589 $2 Million
Q1 2021

May 12, 2021

BUY
$10.34 - $12.81 $1.54 Million - $1.91 Million
149,227 New
149,227 $1.72 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.